Hefren-Tillotson’s WisdomTree Japan Hedged Equity Fund DXJ Stock Holding History

Hefren-Tillotson’s Portfolio DXJ Stock Details DXJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-216	Closed	-$10K	–	37
2015 Q4	$10K	Buy	+216	New	+$11.5K	﹤0.01%	38

Other funds holding DXJ

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WIM

Windhaven Investment Management Boston, Massachusetts $7.79B AUM 7.81% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Investure LLC Charlottesville, Virginia $1.6B AUM 22.38% 1-Year Est. Return

Hefren-Tillotson's DXJ Position: Q1 2016 in Review

Hefren-Tillotson sold out of WisdomTree Japan Hedged Equity Fund (DXJ) in Q1 2016, closing a stake of 216 shares — an estimated $10K sold.

Hefren-Tillotson first reported a position in DXJ in Q4 2015 and held it in 1 quarter. The position peaked at $10K in Q4 2015. 300 funds tracked by Wall St. Rank hold DXJ as of Q1 2016.

Hefren-Tillotson reported no remaining WisdomTree Japan Hedged Equity Fund position as of Q1 2016 after selling out during the quarter.
Hefren-Tillotson sold 216 WisdomTree Japan Hedged Equity Fund shares in Q1 2016, an estimated $10K.
Hefren-Tillotson first reported a position in WisdomTree Japan Hedged Equity Fund in Q4 2015 and held it in 1 quarter.
Hefren-Tillotson's WisdomTree Japan Hedged Equity Fund position peaked at $10K in Q4 2015.
300 funds tracked by Wall St. Rank held WisdomTree Japan Hedged Equity Fund as of Q1 2016.

Based on Hefren-Tillotson's 13F filing for Q1 2016, filed 2 May 2016.